NEUROCHASE TECHNOLOGIES LTD
Company number 13308088 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£40,455
Balance sheet as at 2026-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-04-01
- Employees
- 2 (2026 accounts · was 3 in 2025)
- Registered office
- St Brandon's House, 29 Great George Street, Bristol, England, BS1 5QT
- Postcode
- BS1 5QT
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2026-03-31
- Next due by
- 2027-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-11-13
- Next due by
- 2027-11-27
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current
Group structure
Controlled by NEUROCHASE HOLDINGS LIMITED — since 2021-07-23
From persons-with-significant-control filings on the public register.
Contact details
- Website
- neurochase.com
- Phone
- +44 1179 200112
Next Generation CNS Delivery Targeted Delivery of CNS Therapeutics Most current treatments only target the symptoms of many Neurological diseases but with gene therapies, for the first time, there may be an opportunity to cure many of these conditions. However, many promising treatments are failing clinical trials, not because of the drug itself but because
Competitors Bristol
This company ranks 31 among research and experimental development on biotechnology in Bristol.